← Back to catalogue

ProVeil Hydrogel Membrane

FDA UDI

Class II (US FDA UDI)

by Checkpoint Surgical, Inc.

Identity

Trade Name
ProVeil Hydrogel Membrane FDA UDI
Generic Name
Nerve guide, animal-derived FDA UDI
Device Name
ProVeil™ is a chitosan membrane to provide a non-constricting protection for peripheral nerves. ProVeil™ is designed to be an interface between the nerve and the surrounding tissue for uses to treat nerve injuries. FDA UDI
Model / Reference
PV4030 FDA UDI
Description
ProVeil™ is a chitosan membrane to provide a non-constricting protection for peripheral nerves. ProVeil™ is designed to be an interface between the nerve and the surrounding tissue for uses to treat nerve injuries. FDA UDI

Identifiers

Catalog Number
PV4030 FDA UDI
Primary DI / UDI-DI
B130PV40300 FDA UDI
510(k) Number
K190246 FDA UDI
FDA Product Code
JXI FDA UDI
GMDN Term
Nerve guide, animal-derived FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
882.5275 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI
MRI Safety
MR Safe FDA UDI

Category: Nerve guide, animal-derived

ProVeil Hydrogel Membrane by Checkpoint Surgical, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Nerve guide, animal-derived.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 4612a465-e744-4129-89ff-10a982219dd6 37 fields · synced May 31, 2026